Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07019259 · ClinicalTrials.gov registry record · NA
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
A NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT07019259: Recruiting NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy, sponsored by Yale University.
NCT07019259 is a NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy that is actively recruiting participants, run by Yale University. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07019259, a NA study of Cancer and Chemotherapy-induced Peripheral Neuropathy, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.
Primary Outcome
Measured as proportion of participants adhering to protocol (completing 12 of 18 sessions), with ≥70% of participants adhering to the protocol indicating feasibility
Conditions Studied
Interventions
- DEVICE Anodyne Therapy System
Study Locations (2)
Connecticut
- Yale New Haven Health Smilow York Street Hospital - New Haven
- Yale New Haven Health Park Avenue Medical Center - Trumbull
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07019259 shows while recruiting
NCT07019259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Anodyne Therapy System is the first listed.
NCT07019259 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07019259 about?
NCT07019259 is a clinical study titled "Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors". The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy...
What is the current status of trial NCT07019259?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-30. Estimated completion is 2026-09.
What conditions does trial NCT07019259 study?
This clinical trial studies the following conditions: Cancer, Chemotherapy-induced Peripheral Neuropathy, Childhood Cancer.
What interventions are being tested in trial NCT07019259?
The interventions under investigation include: Anodyne Therapy System (DEVICE).
Who is sponsoring clinical trial NCT07019259?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07019259 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07019259's enrollment target sits among peer trials
20 561st of 615 higher than 47 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI